Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Iordanes Karagiannides

Showing results (1-10 of 33) with videos related to

Pageof 4
Sort By:
Current Opinion in Endocrinology, Diabetes, and Obesity|December 24, 2008
Substance P, obesity, and gut inflammationIordanes Karagiannides, Charalabos Pothoulakis
Annals of the New York Academy of Sciences|December 17, 2008
Neuropeptides, mesenteric fat, and intestinal inflammationIordanes Karagiannides, Charalabos Pothoulakis
Current Opinion in Gastroenterology|October 2, 2007
Obesity, innate immunity and gut inflammationIordanes Karagiannides, Charalabos Pothoulakis
Current Pharmaceutical Design|May 10, 2011
Neuropeptide - adipose tissue communication and intestinal pathophysiologyIordanes Karagiannides, Kyriaki Bakirtzi, Charalabos Pothoulakis
Inflammatory Bowel Diseases|March 13, 2012
Adipose tissue and inflammatory bowel disease pathogenesisChristopher Fink, Iordanes Karagiannides, Kyriaki Bakirtzi, et al.
Experimental Gerontology|August 15, 2002
Adipogenesis and aging: does aging make fat go MAD?James L Kirkland, Tamara Tchkonia, Tamar Pirtskhalava, et al.
The FEBS Journal|August 30, 2008
Apolipoprotein E predisposes to obesity and related metabolic dysfunctions in miceIordanes Karagiannides, Rami Abdou, Aikaterini Tzortzopoulou, et al.
Gastroenterology|August 3, 2011
Neurotensin signaling activates microRNAs-21 and -155 and Akt, promotes tumor growth in mice, and is increased in human colon tumorsKyriaki Bakirtzi, Maria Hatziapostolou, Iordanes Karagiannides, et al.
Cell Metabolism|April 16, 2013
Mechanisms and metabolic implications of regional differences among fat depotsTamara Tchkonia, Thomas Thomou, Yi Zhu, et al.
Gastroenterology|March 8, 2008
Substance P as a novel anti-obesity targetIordanes Karagiannides, Daniel Torres, Yu-Hua Tseng, et al.
Pageof 4

Showing results (1-10 of 33) with videos related to

Sort By:
Pageof 4
Current Opinion in Endocrinology, Diabetes, and Obesity|December 24, 2008
Substance P, obesity, and gut inflammationIordanes Karagiannides, Charalabos Pothoulakis
Annals of the New York Academy of Sciences|December 17, 2008
Neuropeptides, mesenteric fat, and intestinal inflammationIordanes Karagiannides, Charalabos Pothoulakis
Current Opinion in Gastroenterology|October 2, 2007
Obesity, innate immunity and gut inflammationIordanes Karagiannides, Charalabos Pothoulakis
Current Pharmaceutical Design|May 10, 2011
Neuropeptide - adipose tissue communication and intestinal pathophysiologyIordanes Karagiannides, Kyriaki Bakirtzi, Charalabos Pothoulakis
Inflammatory Bowel Diseases|March 13, 2012
Adipose tissue and inflammatory bowel disease pathogenesisChristopher Fink, Iordanes Karagiannides, Kyriaki Bakirtzi, et al.
Experimental Gerontology|August 15, 2002
Adipogenesis and aging: does aging make fat go MAD?James L Kirkland, Tamara Tchkonia, Tamar Pirtskhalava, et al.
The FEBS Journal|August 30, 2008
Apolipoprotein E predisposes to obesity and related metabolic dysfunctions in miceIordanes Karagiannides, Rami Abdou, Aikaterini Tzortzopoulou, et al.
Gastroenterology|August 3, 2011
Neurotensin signaling activates microRNAs-21 and -155 and Akt, promotes tumor growth in mice, and is increased in human colon tumorsKyriaki Bakirtzi, Maria Hatziapostolou, Iordanes Karagiannides, et al.
Cell Metabolism|April 16, 2013
Mechanisms and metabolic implications of regional differences among fat depotsTamara Tchkonia, Thomas Thomou, Yi Zhu, et al.
Gastroenterology|March 8, 2008
Substance P as a novel anti-obesity targetIordanes Karagiannides, Daniel Torres, Yu-Hua Tseng, et al.
Pageof 4